Selenium exposure and the risk of type 2 diabetes: a systematic review and meta-analysis

被引:181
|
作者
Vinceti, Marco [1 ,2 ]
Filippini, Tommaso [1 ]
Rothman, Kenneth J. [2 ,3 ]
机构
[1] Univ Modena & Reggio Emilia, Environm Genet & Nutr Epidemiol Res Ctr CREAGEN, Dept Biomed Metab & Neural Sci, Via Campi 287, I-41125 Modena, Italy
[2] Boston Univ, Sch Publ Hlth, Dept Epidemiol, 715 Albany St, Boston, MA 02118 USA
[3] Res Triangle Inst, RTI Hlth Solut, Res Triangle Pk,3040 E Cornwallis Rd, Durham, NC 27709 USA
关键词
Selenium; Type; 2; diabetes; Systematic review; Meta-analysis; Epidemiology; SERUM TRACE-ELEMENTS; INSULIN-RESISTANCE; TOENAIL SELENIUM; CANCER PREVENTION; OXIDATIVE STRESS; VITAMIN-E; LONGITUDINAL ASSOCIATION; TREND ESTIMATION; FASTING GLUCOSE; PROSTATE-CANCER;
D O I
10.1007/s10654-018-0422-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In 2007, supplementation with the trace element selenium in a trial was unexpectedly found to be associated with an excess risk of type 2 diabetes. Given the concerns raised by these findings and the large number of recent studies on this topic, we reviewed the available literature with respect to this possible association. In this paper, we assessed the results of both experimental and nonexperimental epidemiologic studies linking selenium with type 2 diabetes incidence. Through a systematic literature search, we retrieved 50 potentially eligible nonexperimental studies and 5 randomized controlled trials published through June 11, 2018. To elucidate the possible dose-response relation, we selected for further analysis those studies that included multiple exposure levels and serum or plasma levels. We computed a pooled summary risk ratio (RR) of diabetes according to selenium exposure in these studies. We also computed a RR for diabetes incidence following supplementation with 200 mu g/day of selenium compared with placebo in trials. In the nonexperimental studies, we found a direct relation between selenium exposure and risk of diabetes, with a clear and roughly linear trend in subjects with higher plasma or serum selenium levels, with RR at 140 mu g/L of selenium exposure compared with a referent category of<45 mu g/L equal to 3.6 [95% confidence interval (CI) 1.4-9.4]. A dose-response meta-analysis focusing on studies with direct assessment of dietary selenium intake showed a similar trend. In experimental studies, selenium supplementation increased the risk of diabetes by 11% (RR 1.11, 95% CI 1.01-1.22) compared with the placebo-allocated participants, with a higher RR in women than in men. Overall, results from both nonexperimental and experimental studies indicate that selenium may increase the risk of type 2 diabetes across a wide range of exposure levels. The relative increase in risk is small but of possible public health importance because of the high incidence of diabetes and the ubiquity of selenium exposure.
引用
收藏
页码:789 / 810
页数:22
相关论文
共 50 条
  • [21] Preterm birth and risk of type 1 and type 2 diabetes: systematic review and meta-analysis
    Li, S.
    Zhang, M.
    Tian, H.
    Liu, Z.
    Yin, X.
    Xi, B.
    OBESITY REVIEWS, 2014, 15 (10) : 804 - 811
  • [22] Breastfeeding and Type 2 Diabetes: Systematic Review and Meta-Analysis
    Bernardo Lessa Horta
    Natalia Peixoto de Lima
    Current Diabetes Reports, 2019, 19
  • [23] Risk factors for progression to type 2 diabetes in prediabetes: a systematic review and meta-analysis
    Hu, Shengying
    Ji, Wenting
    Zhang, Yizhu
    Zhu, Wendi
    Sun, Hongyu
    Sun, Yumei
    BMC PUBLIC HEALTH, 2025, 25 (01)
  • [24] Nut consumption and risk of cancer and type 2 diabetes: a systematic review and meta-analysis
    Wu, Lang
    Wang, Zhen
    Zhu, Jingjing
    Murad, Angela L.
    Prokop, Larry J.
    Murad, Mohammad H.
    NUTRITION REVIEWS, 2015, 73 (07) : 409 - 425
  • [25] Insulinemic potential of diet and the risk of type 2 diabetes: a meta-analysis and systematic review
    Farhadnejad, Hossein
    Abbasi, Mehrnaz
    Ahmadirad, Hamid
    Omrani, Morteza
    Jahromi, Mitra Kazemi
    Norouzzadeh, Mostafa
    Saber, Niloufar
    Teymoori, Farshad
    Mirmiran, Parvin
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [26] IDegLira for type 2 diabetes: a systematic review and meta-analysis
    Liu, Yang
    Li, Xuejing
    Zheng, Yingying
    Wang, Xiaoli
    Wang, Xianying
    ENDOCRINE, 2024, 83 (03) : 648 - 658
  • [27] Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis
    Williams, Mia F.
    London, Daniel A.
    Husni, Elaine M.
    Navaneethan, Sankar
    Kashyap, Sangeeta R.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (05) : 944 - 950
  • [28] Adverse childhood experiences and risk of type 2 diabetes: A systematic review and meta-analysis
    Huang, Hao
    Yan, Peipei
    Shan, Zhilei
    Chen, Sijing
    Li, Moying
    Luo, Cheng
    Gao, Hui
    Hao, Liping
    Liu, Liegang
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (11): : 1408 - 1418
  • [29] Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis
    Yao, Qiu-ming
    Wang, Bin
    An, Xiao-fei
    Zhang, Jin-an
    Ding, Liumei
    ENDOCRINE CONNECTIONS, 2018, 7 (01) : 220 - 231
  • [30] Hip circumference, height and risk of type 2 diabetes: systematic review and meta-analysis
    Janghorbani, M.
    Momeni, F.
    Dehghani, M.
    OBESITY REVIEWS, 2012, 13 (12) : 1172 - 1181